CONSEPTUAL STUDY OF VEDANASTHAPAN GANA IN PAIN MANGEMENT
Keywords:
Vedana, Vedana Sthapan Gana, Drug reviewAbstract
ABSTRACT:
The international association for the study of pains defines pain as an unpleasant sensory and emotional experience association. Classical texts of Ayurveda like Charak Samhita explains pain as a separate entity termed as Vedana. There are 50 formulations mentioned in Charak Samhita; each of them having ten different ingredients, one of them is Vedanasthapan Gana. Drugs mentioned in Ayurveda are having firm scientific background but the drugs need revalidation in today’s era. Many drugs in Vedana Sthapana Gana has significant action on Vedana but are not very effective in RA, Osteoarthritis or abdominal pain etc. Most of the doctors think that Vedana Sthapana drug means analgesic but it does not seem true. In this regard, attempt has been made to critical review the Vedana and Vedanasthapan Gana drug mentioned in Ayurvedic classical texts which may abet our understanding of prevention and management of pain in various conditions like Rakta and Shwetpradara, Atyaartava, Karna Roga, Post operative pain and Raktadushtijanya Vikara, Dysmenorrhea etc.
Downloads
References
2. Vaidyak shabdha sindhu edited by kaviraj Umesh Gupta, Published by chokhamba Orientaliya varansi
3. Marathi shabdharatnakar edited by Ke. V.G.Apate, Published by Shri Samarth Sadan Girgao Mumbai.
4. Charak Samhita part 1 edited by, vidhyadhar shukla, published by Chokhamba Sanskrit Pratishthan Delhi.
5. Dravyagun vigyan part 2 edited by Acharya Priyavat Sharma, Published by chokhamba bharati akadami Varanasi.
6. Dravyagun vigyan part 2 edited by prof.Dr.A.P.Deshpande Published by Proficient, Publishing House Pune.
7. सर्जकोऽन्योऽजकर्णः स्याच्छालो मरिचपत्रकः | ...............................
कफपाण्डुश्रुतिगदान् मेहकुष्ठविषव्रणान् ||१८|| भा.प्र्.-पूर्व्.-मिश्र्.- वटादिवर्ग् शालभेद् (सर्जक्)
8. कट्फलः सोमवल्कश्च श्रीपर्णी कुमुदा तथा | ................................................कासश्वासज्वरापहम् ||८४|| ध. नि. कट्फल
9. कदम्बो वृत्तपुष्पश्च नीपस्तु ललनाप्रियः| .....................व्रणसंरोहणश्चापि कासदाहविषापहः ||१०७|| ध. नि. आम्रवर्ग कदम्ब
10. पद्मकाष्ठं पद्मवर्णं पद्मकं हेमवर्णकम् ||१४००|| ..........................................विस्फोटव्रणवीसर्पवमिकुष्ठतृषापहम् |१४०३ कै.नि. ओषधिवर्ग पद्मक
11. निर्यासः शाल्मलेः पिच्छा शाल्मलीवेष्टकोऽपि च |..............................................प्रवाहिकाऽतिसारामकफपित्तास्रदाहनुत् ||४८||भा.प्र.-पू.-मिश्र.वटादिवर्ग मोचरस
12. शिरीषःकलिमो विप्रो मृदुपुष्पः कपीतनः ||९७३|| ......................................निहन्ति दोषवीसर्पशोफकासविषव्रणान् ||९७५|| भा.प्र शिरीष
13. अशोकः शोकनाशश्च विचित्रः कर्णपूरकः | ................................अशोको मधुरो हृद्यः सन्धानीयः सुगन्धिकः |१६४| ध. नि. आम्रवर्ग अशोक
14. नदीकूलप्रियोऽन्यः स्यान्निचुलो जलवेतसः |..............................................कषायः शीतलो रूक्षः सङ्ग्राही जलवेतसः ||७६३| कै.नि. – ओषधिवर्ग जलवेतस
15. एलवालुकमैलेयं सुगन्धि हरिवालुकम् | ..............................बलासविषपित्तास्रकुष्ठमूत्रगदक्रिमीन् ||१००|| भा.प्र् .नि. एलवालुक
16. तुम्बी लम्बा पिण्डफला राजन्या प्रवरापरा |.......................अलाबुपत्रं मधुरं पित्तघ्नं मूत्रशोधनम् ||५४३|| कै.नि. – ओषधिवर्ग कटुतुम्बी
17. Soni et al. A review update on shorea robusta gaertn f. (sal), journal of drug delivery & therapeutics; 2013, 3(6), 127-132
18. P. Sood and r. Shri, A Review on Ethnomedicinal, Phytochemical and Pharmacological Aspects of Myrica esculenta, Indian J Pharm Sci 2018;80(1):02-13
19. Atul Dubey, et al.: Anthocephalus Cadamba: A Review, Pharmacognosy Journal | January 2011 | Vol 2 | Issue 18.
20. Chityanand Tiwari etal.A Review on Padmaka (Prunus Cerasoides D. Don): Different Species and Their Medicinal Uses AYUSHDHARA, 2017;4(1):1051-1055
21. Sarita Verma et al. Case Report on Mocharasa (Haemostyptic Drug) - Action And Uses, Int. J. Ayur. Pharma Research,2017;5(7):48-57
22. Vinita et al: Sirish (Albizia Lebbeck Benth.): A Natural Anti-Allergic Drug, IAMJ: Volume 6, Issue 7, July – 2018
23. Satish A Bhalerao et al., Saraca asoca (Roxb.), De. Wild: An overview, Annals of Plant Sciences, 2014, 3 (07), 770-775
24. Prashith Kekuda TR, Vinayaka ksand Raghavendra HL, Ethnobotanical uses, phytochemistry and biological activities of Salix tetraspermaroxb. (Salicaceae) –Areview, Journal of Medicinal Plants Studies2017;5(5):203-208
25. Ahmad, et al.: Sour Cherry: A high value Unani medicinal fruit, International Journal of Green Pharmacy Jan-Mar 2017 • 11 (1) |4
26. Sakshi Minocha, AN OVERVIEW ON LAGENARIA SICERARIA (BOTTLE GOURD) et al. Journal of Biomedical and Pharmaceutical Research 4 (3) 2015, 04-10
Downloads
Published
How to Cite
Issue
Section
License
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.
